Quantcast

Elekta: IMPAC’s MOSAIQ(TM) Oncology PACS Helps the Department of Radiation Oncology at Mannheim Medical Center, University of Heidelberg, to Achieve Its Goal of Becoming Filmless and Paperless

March 20, 2007

IMPAC Medical Systems, Inc. (IMPAC), an Elekta company (STO:EKTAB) and leading provider of information technology (IT) solutions for oncology care, announces the clinical implementation of MOSAIQ(TM) Oncology PACS at the Mannheim Medical Center Department of Radiation Oncology, in Mannheim, Germany. The Mannheim Medical Center is using IMPAC’s oncology-specific Picture Archiving and Communication System to manage and archive data and images from a broad range of treatment planning systems and imaging devices. The newly released MOSAIQ Oncology PACS offers the department the necessary tools and technology to accomplish its objectives of electronically managing large data sets, department wide access to archived data, and achieve full integration with the proven MOSAIQ(TM) workflow.

“We are very pleased with MOSAIQ Oncology PACS and are excited to start working with it. The installation went very smoothly and the system is very easy to administer” claim Volker Steil, Chief Medical Physicist and Frank Lohr, M.D., Vice Chairman at the Mannheim Department. “Our first goal is to establish an archiving solution for all three of our treatment planning systems and then to manage all of our IGRT planar and volumetric datasets, including cone-beam and conventional computed tomography. MOSAIQ Oncology PACS enables us to easily transport plans and images to a central storage device eliminating the need for individual database and imaging workstation backups”.

MOSAIQ Oncology PACS is designed to manage the increasing volumes of large data sets in radiotherapy and to provide seamless integration with MOSAIQ image-enabled EMR (Electronic Medical Record). As a result, radiation oncology departments may now archive, retrieve and manage information necessary to support advanced IGRT techniques within the context of individual patient charts.

General radiology PACS are not designed to integrate with oncology EMRs and are therefore not suited to complement the workflow within a radiation oncology department. However, MOSAIQ Oncology PACS is inherently linked to MOSAIQ EMR allowing access to the patient’s archived plans, images and supporting documentation in DICOM and non-DICOM formats. As a vendor-independent solution, MOSAIQ Oncology PACS supports the DICOM, DICOM RT and HL7 standards and can interface to a wide range of imaging and treatment planning systems and other PACS” stated Sue Reilly, product manager at IMPAC.

Department Head, Professor Frederik Wenz, M.D stated, “Radiation Oncology at Mannheim Medical Center chose MOSAIQ Oncology PACS because it is the first and only solution in the market that is supporting RO workflow and charting while also accommodating our existing equipment configuration.”

“We are delighted that Mannheim Medical Center has implemented MOSAIQ and MOSAIQ Oncology PACS,” stated James Hoey, President and CEO of IMPAC. “The success of this implementation demonstrates IMPAC’s singular focus and unique understanding of oncology-related workflow and the importance of full functionality and complete integration especially in a mixed planning and delivery environment. We encourage our users to continue taking advantage of MOSAIQ Oncology PACS as the solution to an increasing need for the storage and management of DICOM, DICOM RT and non-DICOM data sets associated with radiation oncology.”

Dr. Frank Lohr will give presentations about Mannheim Medical Center’s technology advancements, including MOSAIQ Oncology PACS, at the Mannheim and Leverkusen symposia in Germany on April 19th and 20th respectively. Additionally, Dr. Lohr will present at the Italian symposia in Verona, Italy planned for May. Further information about MOSAIQ Oncology PACS is available at www.impac.com/mosaiqoncologypacs.

This information was brought to you by Waymaker http://www.waymaker.net

About IMPAC Medical Systems

IMPAC Medical Systems, Inc., an Elekta company, provides healthcare information technology (IT) solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC’s open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that are used in association with diagnosis and treatment environments through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and the quality of patient care. For more information about IMPAC products and services, please call 888-GO-IMPAC or visit www.impac.com.

About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife(R) for non-invasive treatment of brain disorders and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world’s largest supplier of oncology software. Elekta’s systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders. With approx. 2,000 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.

About University of Heidelberg, Mannheim Cancer Center

Mannheim is one of the leading cancer centers in Germany and has a variety of Elekta equipment. It is also a leading teaching hospital providing a range of IMRT courses. The Mannheim Medical Center is a tertiary referral center with 1,300 beds for inpatient treatment. About 66,000 inpatients are treated per year, among which are about 16,000 cancer cases. The Mannheim Medical Faculty is part of the University of Heidelberg, which is the oldest university in Germany having a tradition of more than 650 years.




comments powered by Disqus